You are here : Home / All Sectors / Healthcare / Hospital & Healthcare Services / DR LAL PATHLABS

DR LAL PATHLABS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -1.8% , 1M : -6.6%,1Y : 79.4%
BOM : 539524     NSE : LALPATHLAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 07,2021
Price(EOD): Rs. 2,863.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 23,850.46 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
DR LAL PATHLABS -1.8% -6.6% 79.4%
APOLLO HOSPITALS ENTERPRISE 3.4% 11.1% 156.1%
FORTIS HEALTHCARE 3.9% 8.2% 80.3%
METROPOLIS HEALTHCARE -4.4% 3.9% 87.9%
ASTER DM HEALTHCARE 2.1% 7.1% 60.2%
NARAYANA HRUDAYALAYA 0.4% -2.8% 49.8%
THYROCARE TECHNOLOGIES 0.4% 11.2% 110.6%
SHALBY 12.6% 30.1% 81.8%
KOVAI MEDICAL CENTER & HOSPITAL 3.9% 22% 129.3%


FUNDAMENTAL ANALYSIS OF DR LAL PATHLABS

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than DR LAL PATHLABS Premium


VALUATION OF DR LAL PATHLABS

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
106.92
P/E Calculated based on EPS of 26.78
[ Mar2020 - Standalone Results ]

24.27
P/B Calculated based on Book Value of 117.99
[ Mar2020 - Standalone Results ]

19.81
P/S Calculated based on Revenues of 1204.1 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than DR LAL PATHLABS Premium


FAIR VALUE OF DR LAL PATHLABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
152%
135%
117%

SHARE PRICE MOMENTUM OF DR LAL PATHLABS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
5.64%
13.22%
16.2%
16.02%
37.6%
71.47%
80.9%
81.41%
QtrlyTrend
8
Latest Qtr: Dec2020

DR LAL PATHLABS related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 1.6% 9.7% 58.6%
S&P BSE 200 1.4% 1.4% 62.8%
S&P BSE 250 LARGEMIDCAP 1.4% 1.4% 63.2%
S&P BSE ALLCAP 1.4% 1.9% 66.8%
S&P BSE 500 1.3% 1.7% 65.5%
S&P BSE MIDSMALLCAP 1.2% 3.2% 93.8%
S&P BSE 150 MIDCAP 1% 2.3% 88.5%
S&P BSE 400 MIDSMALLCAP 1% 3.1% 94.6%
S&P BSE SMALL CAP 0.9% 5.7% 107.3%
S&P BSE SMALLCAP SELECT INDEX -0.1% 4.1% 94.5%
NSE Indices1W1M1Y
NIFTY 200 1.4% 1.4% 61.8%
NIFTY 500 1.4% 1.7% 65%
NIFTY LARGE MIDCAP 250 1.2% 1.7% 72.6%
NIFTY FREE MIDCAP 100 1.2% 2.2% 91%
NIFTY MID SMALL400 1.1% 3.2% 95.2%
NIFTY MIDCAP150 0.9% 2.1% 87.7%

FAQ [Frequently Asked Questions]


Is LALPATHLAB good for long term investment?

As on 07-May-2021, the Fundamentals of LALPATHLAB are Strong and hence it's good for long term investment! See Financial Performance of DR LAL PATHLABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is LALPATHLAB UnderValued or OverValued?

As on 07-May-2021, LALPATHLAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of LALPATHLAB ?

As on 07-May-2021, the Intrinsic Value of LALPATHLAB is Rs. 1,217.29 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,136.88
Fair Value [Median EV / Sales Model] : Rs. 1,217.29
Fair Value [Median Price / Sales Model] : Rs. 1,316.85
Median Fair Value of LALPATHLAB : Rs. 1,217.29

Is LALPATHLAB trading at a Premium or Discount?

As on 07-May-2021, LALPATHLAB is trading at a Premium of 135% based on the Median Intrinsic Value!

Is it right time to buy LALPATHLAB shares?

As on 07-May-2021, LALPATHLAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of LALPATHLAB?

Check out Financials of Industry Peers using below links:
Financials of APOLLO HOSPITALS ENTERPRISE LTD
Financials of FORTIS HEALTHCARE LTD
Financials of METROPOLIS HEALTHCARE LTD
Financials of ASTER DM HEALTHCARE LTD
Financials of NARAYANA HRUDAYALAYA LTD
Financials of THYROCARE TECHNOLOGIES LTD
Financials of SHALBY LTD
Financials of KOVAI MEDICAL CENTER & HOSPITAL LTD
Financials of INDRAPRASTHA MEDICAL CORPORATION LTD
Financials of KMC SPECIALITY HOSPITALS (INDIA) LTD

What are the Frequent Comparisons with LALPATHLAB?

DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs METROPOLIS HEALTHCARE LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs ASTER DM HEALTHCARE LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs NARAYANA HRUDAYALAYA LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs THYROCARE TECHNOLOGIES LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs SHALBY LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KOVAI MEDICAL CENTER & HOSPITAL LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs INDRAPRASTHA MEDICAL CORPORATION LTD
DR LAL PATHLABS LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs KMC SPECIALITY HOSPITALS (INDIA) LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z